Skip to main content
. 2022 Nov 11;23(22):13915. doi: 10.3390/ijms232213915

Figure 1.

Figure 1

Effect of GSK343 treatment on human GB cell viability. MTT assay revealed that the treatment with GSK343 at the concentrations of 1, 10, 25 and 50 μM significantly reduced viability in U87, U138, and A172 cell lines, in a concentration-dependent manner both at 24 h (A) and 48 h (B) compared to the control group. Data are representative of at least three independent experiments. (A) ## p < 0.01 vs. Ctr; ### p < 0.001 vs. Ctr. (B) ### p < 0.001 vs. Ctr.